經濟部產業發展署-活動報報「活動報報」網站，第一手掌握產業發展署所有活動資訊

Date:

Friday 29 July, 2022

Time:

9:00 am – 12:00 pm Taipei [11:00 am – 2:00 pm AEST]

Venue:

Room 703, Hall 2, Taipei Nangang Exhibition Center

08:30-09:00

Registration and Morning Coffee

09:00-09:10

Welcome Remarks

Ms Jenny Bloomfield, Australian Representative in Taiwan

Opening Remarks

Dr Chung-hsiu Wu

Director, Biotechnology and Pharmaceutical Industries Promotion Office, MOEA

Chairman, Taiwan Bio Industry Organisation

09:10-09:20

Australia: A powerhouse for science and innovation in Biotechnology

Rhett Miller

Head of Greater China International Health Team

Trade and Investment Commissioner, Austrade

Part 1- Presentation: Australia Clinical Trials Capabilities

09:20-09:55

Topic

Speaker

George Clinical – Your CRO Partner for Australia and across the Globe

James Cheong

Chief Executive Officer

George Clinical

US Team capability, Phase I capability and Experiences (ANZ), NVT/PPC integration

John Moller

Chief Executive Officer

Novotech

Southern Star Research: Early Phase Clinical Study Specialists

Chris Stellatos, Director

Southern Star Research

Neuroscience Trials Australia (NTA): The CRO for all your neuroscience trials in Australia and beyond

Kathy Skoff‌

Senior Business Development Manager

Neuroscience Trials Australia

Nucleus Network : Your Premier Early Phase Clinical Trial Solution Provider Across Australia and USA

Jeffery Wong

Director of Business Development

Nucleus Network

Local knowledge, global network: Bioanalytical solutions for Australia and beyond

Angela Luttick

EVP, Commercial

360biolabs

Conducting Clinical Trials in Australia: Corporate Structuring & R&D Incentives

Blair Lucas, Partner

Acclime Australia

09:55-10:10

Q&A

Part 2- Presentations: Australian Innovative Biotech Company Presentation

10:10-10:35

Topic

Speaker

MiCheck® Prostate for Detection of Aggressive Prostate Cancer

Dr Brad Walsh

Chief Executive Officer

Minomic International

Discovery, development, and market authorisation of microbiome-based therapies 

Thomas Mitchell

Chief Executive Officer

BiomeBank

Data driven development of microbiome-based therapeutics

Trent Muno

SVP Therapeutics
Microba Life Sciences

Your Australian Future: Global Talent Visa Program

Pip Butler

Director Global Talent, Hong Kong and North Asia

Global Australia Taskforce

10:35-10:50

Q&A

10:50-11:05

Tea Break

Part 3: Taiwan Precision Medicine Company Presentation

11:05 – 11:35

Topic

Speaker

Code to cure, an enterprise cloud-native BioMed-IT platform to empower biotech and precision medicine industries to innovate at scale and speed

Allen Chang

Chief Executive Officer

ATGENOMIX

One-stop services for cell-based products and bioassays

Shing-Mou Lee

Chief Executive Officer & Lab Head

TACT, Executive Director

EMO Biomedicine

Universal antibody lock makes antibody drugs safer and effective

Yun-Chi Lu

Chief Executive Officer

PrecisemAb Biotech

A novel nanobody-based trispecific T cell engager (Nb-TriTE) for cancer immunotherapy

Shao-Chih Chiu

Chief R&D Officer

Shine-On BioMedical

Biologic drug industry pain points and how we can help to fill the gap

Alan Chang, Ph.D.,

Chief Executive Officer

Taron Solutions

Research results of lung cancer urine detection technology

I-Shu Lee, Ph.D.

Chief Executive Officer

VITAE Biomedical

11:35-11:50

Q&A

12:00

Event Closing